Association of dopamine agonist use with impulse control disorders in Parkinson disease.

By Daniel Weintraub, A. Siderowf, Marc N. Potenza, J. Goveas, K. Morales, J. Duda, P. Moberg, M. Stern. Archives of Neurology, 2006

660 citations recorded by the source corpus.

Subfields: Epidemiology, Neurology

View Paper: https://www.semanticscholar.org/paper/600212c37528d9ee5d3e6cc11f1dbb14723dc416

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Marc N. Potenza
2. Matthias Brand
3. Michel Tuan Pham
4. Shiri Melumad

In Neurology

1. Daniel Weintraub
2. Valerie Voon

Citations in the corpus

• Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. (2010, background): “In this study, after controlling for levodopa exposure and other covariates, no dopamine agonist dosing effect was found, though there are reports to the contrary.(2,16) As the study was crosssectional, a selection bias for current dopamine agonist dosage may have existed that obscured a dosing effe”
• Introduction to Behavioral Addictions (2010, background): “A higher levo-dopa dose equivalence was associated with greater likelihood of having a behavioral addiction (59).”